Cholestatic ichterus secondary to non-metastatic prostate adenocarcinoma

Amaç & Hipotez:Bazı neoplastik hastalıklara eşlik edebilen paraneoplastik sendromlar, zaman zaman bulgu ve semptomların yorumlanmasında güçlüklere sebep olabilmektedir.

📊

Temel Bulgular & Veri:İntrahepatik kolestaz paraneoplastik sendromların nadir görülen bir klinik prezantasyonudur.

💡

Sonuç & Katkı:İlk klinik bulgusu intrahepatik kolestaz olan prostat adenokarsinomalı bir olguyu sunuyoruz.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Paraneoplastik sendromlar · Adenokarsinom · Kolestaz

Özet

Bazı neoplastik hastalıklara eşlik edebilen paraneoplastik sendromlar, zaman zaman bulgu ve semptomların yorumlanmasında güçlüklere sebep olabilmektedir. İntrahepatik kolestaz paraneoplastik sendromların nadir görülen bir klinik prezantasyonudur. İlk klinik bulgusu intrahepatik kolestaz olan prostat adenokarsinomalı bir olguyu sunuyoruz.

Abstract

Paraneoplastic syndromes may accompany some neoplastic diseases and cause some difficulty in interpretation of signs and symptoms. Intrahepatic cholestasis is a rare clinical presentation of paraneoplastic syndromes. We report a case with prostatic adenocarcinoma whose first clinical signs presented as intrahepatic cholestasis.

Anahtar kelimeler

Paraneoplastik sendromlar Adenokarsinom Kolestaz intrahepatik Prostat neoplazmları Paraneoplastic Syndromes Adenocarcinoma Cholestasis Intrahepatic Prostatic Neoplasms

🔖

Bu Makaleye Atıf Yap

KARASU, Z., VARDAR, R., EVRENGİL, H., AKARCA, U. S., ERSÖZ, G., MUSOĞLU, A. (2000). Cholestatic ichterus secondary to non-metastatic prostate adenocarcinoma. Turkish Journal of Gastroenterology, Cilt: 11 - Sayı: 4, 346–348. https://ajindex.com/articles/410514

Kaynakça (1)

.Iannuzzi MC, Toews GB. Neoplasms of the lung. In: Stein JH, ed. Internal Medicine. 3rd ed. Little, Botton: Brown and Company 1990; 720-1. 2).Cotran RS, Kumar V, Robbins SL. Neoplasia. Pathologic basis of disease 5th Edition. Philadelphia: W.B. Saunders Company 1994, 295-6. 3).Kew MC. Tumors of the liver. In: Zakim D, ed. Hepatology. 3rd Philadelphia: W.B. Saunders Comapany, 1996, 1516-7. 4).Landgarten S, Soper ML. Hypercalcemia corrected by orchiectomy in a patient with carcinoma of the prostate. J Okla State Med Assoc 1978; 71: 288-9. 5).Iriarte Soldevilla JI, Unda Urzaiz M, Angulo Cuesta J, et al. Trigeminal neuralgia. First manifestation of adenocarcinoma of the prostate. Arch Esp Urol 1993; 46: 54-6. 6).Riambau E, Roma J, Samon R. Membraneous glomerulonephritis and adenocarcinoma of the prostate: association or coincidence? Med Clin (Barc) 1988; 90: 179. 7).Moris de la Tassa J, Claros Gonzalez I, Garcia-Alcalde Fernandez ML, et al. Cholestasis and prostatic carcinoma. Description of a case and review of paraneoplastic cholestasis. Med Clin (Barc) 1991; 96:22-5. 8).Ben-Ishay D, Slavin S, Levij IS, Eliakim M. Obstructive jaundice associated with carcinoma of the prostate. Isr J Med Sci 1975; 11:838-44. 9).Reddy AN, Grosberg SJ, Wapnick S. Intermittent cholestatic jaundice and nonmetastatic prostatic carcinoma. Arch Intern Med 1977; 137:1616-8. 10).Dourakis SP, Sinani C, Deutsch M, et al. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J Gastroenterol Hepatol 1997; 9:311-4. 11).Ishibe T, Usui T, Nihira H. Prognostic value of liver function tests in carcinoma of the prostate. Urol Int 1976; 31:205. 12).Bloch WE, Bloch NL. Metastatic prostate cancer presenting as obstructive jaundice. Urology 1992; 40:456-7. 13).The Veterans administration Cooperative Urological Research group: Treatment and survival of patients with cancer of prostate. Surg Gynecol Obstet 1967; 124:1011.